Literature DB >> 9171269

Status of lung transplant recipients surviving beyond five years.

C Chaparro1, M Scavuzzo, T Winton, S Keshavjee, S Kesten.   

Abstract

BACKGROUND: Prolonged survival after lung transplantation is now commonplace as a result of advances in surgical techniques and postoperative management protocols. Although 1- and 5-year functional and survival data after lung transplantation are well known, sparse information is available regarding functional status of recipients surviving beyond 5 years.
METHODS: The medical records and pulmonary function study results of lung transplant recipients who had survived at least 5 years as of September 1995 were retrospectively reviewed.
RESULTS: Of the 76 transplantations performed between November 1983 and September 1990, 30 (39.5%) were double lung transplantations, and 46 (60.5%) were single lung transplantations. Thirty-one recipients were alive 5 years after transplantation (12 double lung transplantations, 19 single lung transplantations). The 5-, 6-, and 7-year survival rates were 44%, 34%, and 29%, respectively. There was no association or difference in cytomegalovirus status, sex, and blood group between those who died within 5 years and those who survived beyond 5 years. The median percent predicted FEVs for single and double lung transplant recipients were as follows: 5 yrs-75%, 75%; 6 years-73%, 75%; 7 years-68%, 73%. The proportion of recipients with bronchiolitis obliterans syndrome according to published criteria was as follows: stage 0, 32%; stage I, 19%; stage II, 16%; and stage III, 19%. The functional status (i.e., active, working, disabled) 5 years after transplantation was as follows: active/working, 74%; active but not working, 13%; some limitation/independent, 10%; and disabled, 3%.
CONCLUSION: Bronchiolitis obliterans syndrome is a frequent occurrence in long-term survivors. Nevertheless, in spite of this condition, most recipients have acceptable lung function, are active, and are generally working.

Entities:  

Mesh:

Year:  1997        PMID: 9171269

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  5 in total

1.  Impact of donor and recipient hepatitis C status in lung transplantation.

Authors:  Brian R Englum; Asvin M Ganapathi; Paul J Speicher; Brian C Gulack; Laurie D Snyder; R Duane Davis; Matthew G Hartwig
Journal:  J Heart Lung Transplant       Date:  2015-10-09       Impact factor: 10.247

2.  Quality of recipient-caregiver relationship and psychological distress are correlates of self-care agency after lung transplantation.

Authors:  Annette DeVito Dabbs; Lauren Terhorst; Mi-Kyung Song; Diana A Shellmer; Jill Aubrecht; Mary Connolly; Mary Amanda Dew
Journal:  Clin Transplant       Date:  2012-09-24       Impact factor: 2.863

3.  Predictors and outcomes of health-related quality of life in caregivers of cardiothoracic transplant recipients.

Authors:  L Myaskovsky; D M Posluszny; R Schulz; A F DiMartini; G E Switzer; A DeVito Dabbs; M L McNulty; R L Kormos; Y Toyoda; M A Dew
Journal:  Am J Transplant       Date:  2012-09-07       Impact factor: 8.086

4.  Bronchial artery revascularization in lung transplantation: a systematic review and meta-analysis.

Authors:  Danial Ahmad; Thomas J O'Malley; Andrew M Jordan; Elizabeth J Maynes; Abhiraj Saxena; Kyle W Prochno; Taufiek K Rajab; Howard T Massey; Richard C Daly; Vakhtang Tchantchaleishvili
Journal:  J Thorac Dis       Date:  2022-09       Impact factor: 3.005

5.  Right ventricular ejection fraction during exercise as a predictor of mortality in patients awaiting lung transplantation: a cohort study.

Authors:  Nedim Selimovic; Bert Andersson; Odd Bech-Hanssen; Milan Lomsky; Gerdt C Riise; Bengt Rundqvist
Journal:  BMJ Open       Date:  2013-04-08       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.